It was reported that a patient implanted with a 21mm aortic valve for 3 months 28 days had an explant procedure due to endocarditis.The patient presented with new vegetation on the aortic and mitral valves.As the patient had symptoms of a recent embolic event, the patient was brought to the operative room for the high-risk surgical procedure.The entire aortic valve was resected with what appeared to be either abscess or destruction of the annulus into the level of the coronary ostia.The patient underwent total root replacement with a 23mm valve and 28mm valsalva graft.The native mitral valve was patched with bovine pericardial patch.Cabgx3 was performed.Intra-aortic balloon pump was placed.Eventually, the patient weaned off cardiopulmonary bypass with significant inotropic and vasopressor support.The patient expired in the operating room.
|
Prosthetic endocarditis with or without vegetation, of valves and annuloplasty rings is a serious complication of valve replacement and valve repair surgeries despite improvements in prostheses types, surgical techniques, and infection control measures.This infection is generally categorized into early (onset usually less than 60 days postoperative) and late (onset greater than 60 days post-implantation).Late prosthetic endocarditis resembles native valve endocarditis in terms of etiological microbes, and sources of contamination are presumably similar.Late endocarditis occurs due to the implant being seeded from an infection or microbial contamination from elsewhere in the body.Dental, genitourinary, and gastrointestinal manipulation are known causes of transient bacteremia, which can place a patient at risk for prosthetic endocarditis.Additional procedures placing patients at risk for prosthetic endocarditis include urethral catheterization, colonoscopy, barium enemas, and surgical procedures.Late prosthetic endocarditis is not in any way related to the sterilization or packaging process of the device.A definitive root cause could not be determined; however, it is likely that patient related factors contributed to the event.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.
|